The treatment efficacy of angiogenesis inhibitor could be underestimated at an early stage based on tumor volume changes. Intravoxel incoherent motion diffusion‐weighted imaging (IVIM‐DWI) can quantitatively assess tumors at the… Click to show full abstract
The treatment efficacy of angiogenesis inhibitor could be underestimated at an early stage based on tumor volume changes. Intravoxel incoherent motion diffusion‐weighted imaging (IVIM‐DWI) can quantitatively assess tumors at the cellular level, but it is unclear whether it can provide useful information for assessing treatment response of anti‐angiogenic treatment for lung adenocarcinoma.
               
Click one of the above tabs to view related content.